The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis

The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis

Introduction: Cetuximab and panitumumab has been used clinically to treat metastatic colorectal cancer for over 15 years. Before the treatment is given, it is necessary to determine the KRAS mutation status because it would lead to drug resistance. tumor tissue sample is traditionally used for genotyping of cancer. In recent years, the biopsy sample liquid has been intensively investigated as a substitute for tumor tissue samples for non-invasive and better presentation of tumor heterogeneity.

The purpose of this study was to systematically summarize the accuracy of the measurement of KRAS mutations in colorectal cancer using the cell-free DNA in the sample liquid biopsy, the tumor tissue samples as reference (gold standard).
Methods and analysis: We will find literature in the following databases: Pubmed, Embase, and the Cochrane Library. systemic review and meta-analysis will be conducted to summarize the accuracy of the measurement of KRAS mutations in colorectal cancer using biopsy samples of liquid and subgroup analyzes will be performed on different testing platforms, and in colorectal cancer metastatic and non-metastatic.
Timeline: The research will begin on June 1, 2020, and is expected to be completed date of 1 November 2020.


Ethics and deployment: Ethics approval will not be required because the data obtained and analyzed in this study will not be in each patient. The results of the research will be disseminated as an official publication in peer-reviewed

A PCR-based NGS protocol for whole genome sequencing of West Nile virus 2 direct descendant of biological specimens.

Lineage 2 West Nile virus (WNV) strain has been involved in a severe outbreak of encephalitis in humans and equines which are in Europe. WNV molecular characterization is important for the development of diagnostic tests, and to obtain molecular information, which is necessary for epidemiological investigations in areas at risk of virus transmission.

For whole-genome sequencing of strains of WNV lineage 2, directly from biological specimens, PCR-based NGS protocol developed. This method is applied to the WNV-positive specimens were obtained from animals, human and mosquito hosts in Greece. Outcomes of the application shows that, even in the case of a low viral titers, developed PCR-based NGS approach capable of providing whole genome sequence of strain lineage 2 WNV.

The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis
The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis

The latest trends in molecular diagnostics yeast infection: PCR for NGS.

The incidence of opportunistic yeast infections in humans has increased in recent years. These infections are difficult to treat and diagnose, partly because the large number and wide variety of species that can be underlying infection.

Moreover, resistance to one or more of antifungal drugs in a strain that infects more and more reported, severely limiting therapeutic options and to show the need for rapid detection of infecting agents and the profile of its drug susceptibility.

Current methods for species identification of constraints and shortage of sensitivity and specificity were satisfactory, and often require a previous culture of the infecting agent, which delays diagnosis.

Recently developed high-throughput technologies such as next-generation sequencing or proteomics opens a completely new way to diagnose more sensitive, accurate and rapid pathogenic yeast. These approaches are the focus of intensive research, but the translation to the clinic needed to overcome important challenges. In this review, we provide an overview of existing approaches and recently appeared which can be used in the identification of the yeast pathogens and their drug resistance profile.

CD79B Antibody

DF6767 200ul
EUR 420

CD79B Antibody

CSB-PA004958KA01HU- each
EUR 402
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

CD79B Antibody

CSB-PA004958KA01HU-100ul 100ul
EUR 466.8
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

CD79B Antibody

1-CSB-PA004958LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF; Recommended dilution: IF:1:50-1:200

CD79B Antibody

1-CSB-PA005233
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

CD79b Antibody

F44972-0.08ML 0.08 ml
EUR 140.25
Description: The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-beta protein of the B-cell antigen component. Alternatively spliced transcript variants encoding different isoforms have been described.

CD79b Antibody

F44972-0.4ML 0.4 ml
EUR 322.15
Description: The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-beta protein of the B-cell antigen component. Alternatively spliced transcript variants encoding different isoforms have been described.

CD79b Antibody

R31586 100 ug
EUR 356.15
Description: Cluster of Differentiation 79b, is a human gene mapped to 17q23.3. The CD79b protein together with the relatedCD79aprotein, forms a dimer associated with membrane bound immunoglobulin in B-cells, thus forming the B-cell antigen receptor (BCR) which is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). CD79b also enhances phosphorylation of CD79a, possibly by recruiting kinases, or by recruiting proteins which bind to CD79a and protect it from dephosphorylation.

CD79b Antibody

RQ5654 100 ug
EUR 356.15
Description: CD79b molecule, immunoglobulin-associated beta, also known as CD79B (Cluster of Differentiation 79B), is a human gene. By fluorescence in situ hybridization, It is mapped to 17q23.3. The CD79B protein together with the related CD79A protein, forms a dimer associated with membrane bound immunoglobulin in B-cells, thus forming the B-cell antigen receptor (BCR) which is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). CD79b also can enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation.

CD79b Antibody

V8930-100UG 100ug
EUR 349.3
Description: The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8930-20UG 20ug
EUR 153.3
Description: The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8930SAF-100UG 100ug
EUR 349.3
Description: The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V9128-100UG 100ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V9128-20UG 20ug
EUR 153.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V9128SAF-100UG 100ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3804-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3804-20UG 20 ug
EUR 153.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3804SAF-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3806-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3806-20UG 20 ug
EUR 153.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3806SAF-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3810-100UG 100 ug
EUR 349.3
Description: Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation. [UniProt]

CD79b Antibody

V3810-20UG 20 ug
EUR 153.3
Description: Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation. [UniProt]

CD79b Antibody

V3810SAF-100UG 100 ug
EUR 349.3
Description: Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation. [UniProt]

CD79b Antibody

V3956-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3956-20UG 20 ug
EUR 153.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3956SAF-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V7631-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V7631-20UG 20 ug
EUR 153.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V7631SAF-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8265-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8265-20UG 20 ug
EUR 153.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8265SAF-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8457-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8457-20UG 20 ug
EUR 153.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8457SAF-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79B Rabbit pAb

A2033-100ul 100 ul
EUR 369.6

CD79B Rabbit pAb

A2033-200ul 200 ul
EUR 550.8

CD79B Rabbit pAb

A2033-20ul 20 ul
EUR 219.6

CD79B Rabbit pAb

A2033-50ul 50 ul
EUR 267.6

CD79B Rabbit mAb

A4362 20 μL
EUR 18

CD79b antibody (PE)

61R-1273 100 tests
EUR 444
Description: Mouse monoclonal CD79b antibody (PE)

CD79b antibody (PE)

61R-CD79bbMSPE 100 ug
EUR 354
Description: Hamster monoclonal CD79b antibody (PE)

CD79B Antibody (HRP)

20-abx312629
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

CD79B Antibody (FITC)

20-abx312630
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

CD79b Antibody (FITC)

abx139338-100tests 100 tests
EUR 510

CD79b antibody (FITC)

61R-1107 100 tests
EUR 483.6
Description: Mouse monoclonal CD79b antibody (FITC)

CD79b antibody (FITC)

61R-CD79bbMSFT 500 ug
EUR 548.4
Description: Hamster monoclonal CD79b antibody (FITC)

Human CD79B Antibody

32245-05111 150 ug
EUR 313.2

CD79B Antibody (Biotin)

20-abx312631
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

CD79B cloning plasmid

CSB-CL004958HU1-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the CD79B gene.

CD79B cloning plasmid

CSB-CL004958HU2-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the CD79B gene.

CD79b antibody (biotin)

61R-CD79bbMSBT 500 ug
EUR 548.4
Description: Hamster monoclonal CD79b antibody (biotin)

CD79B Blocking Peptide

AF4649-BP 1mg
EUR 234

CD79B Blocking Peptide

DF6767-BP 1mg
EUR 234

CD79b Blocking Peptide

20-abx161330
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

CD79b Blocking Peptide

20-abx161331
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

CD79B, human recombinant

7318-50 each
EUR 438

CD79b Polyclonal Antibody

41662-100ul 100ul
EUR 302.4

CD79b Polyclonal Antibody

41662-50ul 50ul
EUR 224.4

CD79B Recombinant Protein

91-738 0.05 mg
EUR 821.4
Description: CD79B is a single-pass type I membrane protein. CD79B contains one Ig-like V-type domain and one ITAM domain. CD79B is required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR), which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. CD79B enhances phosphorylation of CD79A, possibly by recruiting kinases that phosphorylate CD79A or by recruiting proteins that bind to CD79A and protect it from dephosphorylation.

CD79b Polyclonal Antibody

ABP52986-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of CD79b from Human. This CD79b antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD79b

CD79b Polyclonal Antibody

ABP52986-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of CD79b from Human. This CD79b antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD79b

CD79b Polyclonal Antibody

ABP52986-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of CD79b from Human. This CD79b antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD79b

CD79b Polyclonal Antibody

ES3985-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against CD79b from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

CD79b Polyclonal Antibody

ES3985-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against CD79b from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

Anti-Ms CD79b PE

1P-584-C025 0.025 mg
EUR 135.6

Anti-Ms CD79b PE

1P-584-C100 0.1 mg
EUR 223.2

Anti-Hu CD79b PE

1P-676-T025 25 tests
EUR 168

Anti-Hu CD79b PE

1P-676-T100 100 tests
EUR 288

Anti-Hu CD79b APC

1A-676-T025 25 tests
EUR 168

Anti-Hu CD79b APC

1A-676-T100 100 tests
EUR 288

Anti-Ms CD79b FITC

1F-584-C100 0.1 mg
EUR 200.4

Anti-Hu CD79b FITC

1F-676-T025 25 tests
EUR 146.4

Anti-Hu CD79b FITC

1F-676-T100 100 tests
EUR 244.8

CD79B protein (His tag)

80R-2614 100 ug
EUR 386.4
Description: Purified recombinant CD79B protein

Human CD79B ELISA KIT

ELI-34173h 96 Tests
EUR 988.8

Mouse Cd79b ELISA KIT

ELI-25434m 96 Tests
EUR 1038

Anti-Ms CD79b Purified

11-584-C100 0.1 mg
EUR 178.8

Anti-Hu CD79b Purified

11-676-C025 0.025 mg
EUR 118.8

Anti-Hu CD79b Purified

11-676-C100 0.1 mg
EUR 189.6

Human CD79B shRNA Plasmid

20-abx950695
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse CD79B shRNA Plasmid

20-abx970984
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

CD79b antibody (Azide Free)

10R-CD79bbMSP 500 ug
EUR 678
Description: Hamster monoclonal CD79b antibody (Azide Free)

CD79B Antibody, HRP conjugated

1-CSB-PA004958LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

CD79B Recombinant Protein (Rat)

RP194027 100 ug Ask for price

CD79B Antibody, FITC conjugated

1-CSB-PA004958LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

CD79B Human Recombinant Protein

PROTP40259 Regular: 20ug
EUR 380.4
Description: CD79B Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 155 amino acids (29-159a.a) and having a molecular mass of 17.7kDa. ;CD79B is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

CD79B Recombinant Protein (Human)

RP006418 100 ug Ask for price

CD79B Recombinant Protein (Human)

RP006421 100 ug Ask for price

CD79B Recombinant Protein (Mouse)

RP122705 100 ug Ask for price

CD79B Antibody, Biotin conjugated

1-CSB-PA004958LD01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Cd79b ORF Vector (Rat) (pORF)

ORF064677 1.0 ug DNA
EUR 607.2

CD79B ORF Vector (Human) (pORF)

ORF002140 1.0 ug DNA
EUR 114

CD79B ORF Vector (Human) (pORF)

ORF002141 1.0 ug DNA
EUR 114

Cd79b ORF Vector (Mouse) (pORF)

ORF040903 1.0 ug DNA
EUR 607.2

Anti-Hu CD79b PerCP-Cy5.5

T9-676-T025 25 tests
EUR 235.2

Anti-Hu CD79b PerCP-Cy5.5

T9-676-T100 100 tests
EUR 422.4

CD79B ELISA Kit (Human) (OKCA01119)

OKCA01119 96 Wells
EUR 1015.2
Description: Description of target: Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 1.56 pg/mL

CD79B ELISA Kit (Mouse) (OKCA01632)

OKCA01632 96 Wells
EUR 1015.2
Description: Description of target: Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 0.04 ng/mL

Recombinant Human CD79B/B29 Protein

RP00565 10 μg
EUR 265.2

Human CD79B Antibody (Biotin Conjugate)

32245-05121 150 ug
EUR 442.8

CD79b MonoSpecific Antibody, Unconjugated-20ug

974-MSM4-P0 20ug
EUR 279.6

CD79b MonoSpecific Antibody, Unconjugated-100ug

974-MSM4-P1 100ug
EUR 513.6

Recombinant Human CD79B/B29 (C-6His)

CA29-10ug 10ug
EUR 242.4
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human CD79B/B29 (C-6His)

CA29-1mg 1mg
EUR 2739.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human CD79B/B29 (C-6His)

CA29-500ug 500ug
EUR 1935.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human CD79B/B29 (C-6His)

CA29-50ug 50ug
EUR 595.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Cd79b sgRNA CRISPR Lentivector set (Rat)

K7064001 3 x 1.0 ug
EUR 406.8

Rat Anti Mouse Cd79b Monoclonal Antibody

CABT-49746RM 0.2 mg
EUR 920.4

CD79B sgRNA CRISPR Lentivector set (Human)

K0403901 3 x 1.0 ug
EUR 406.8

Cd79b sgRNA CRISPR Lentivector set (Mouse)

K3317901 3 x 1.0 ug
EUR 406.8

Human, CD79B Human Recombinant Protein, Sf9

PROTP40259-1 Regular: 10ug
EUR 380.4
Description: CD79B Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 140 amino acids (29-159a.a.) and having a molecular mass of 16.3kDa (Molecular size on SDS-PAGE will appear at approximately 18-28 kDa).;CD79B is expressed with a 9 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.

Cd79b 3'UTR GFP Stable Cell Line

TU153528 1.0 ml Ask for price

CD79B 3'UTR GFP Stable Cell Line

TU053910 1.0 ml
EUR 1672.8

Cd79b 3'UTR GFP Stable Cell Line

TU252001 1.0 ml Ask for price

Human CD79B AssayLite Antibody (RPE Conjugate)

32245-05151 150 ug
EUR 513.6

Human CD79B AssayLite Antibody (APC Conjugate)

32245-05161 150 ug
EUR 513.6

Cluster of Differentiation 79B (CD79B) Antibody

20-abx312628
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Cluster of Differentiation 79B (CD79b) Antibody

abx139336-01mg 0.1 mg
EUR 427.2

Cluster of Differentiation 79B (CD79b) Antibody

20-abx121330
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Cluster of Differentiation 79B (CD79b) Antibody

20-abx121331
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Cluster of Differentiation 79B (CD79B) Antibody

abx117180-100ug 100 ug
EUR 560.4

Cluster of Differentiation 79B (CD79B) Antibody

abx028989-400ul 400 ul
EUR 627.6

Cluster of Differentiation 79B (CD79B) Antibody

abx028989-80l 80 µl
EUR 343.2

Cluster of Differentiation 79B (CD79B) Antibody

20-abx323680
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Cluster of Differentiation 79B (CD79b) Antibody

abx413392-01mg 0.1 mg
EUR 526.8

Cluster of Differentiation 79B (CD79b) Antibody

abx413832-02mg 0.2 mg
EUR 678

Cluster of Differentiation 79B (CD79b) Antibody

abx413835-25ug 25 ug
EUR 326.4

Cluster of Differentiation 79B (CD79b) Antibody

abx413836-02mg 0.2 mg
EUR 678

Cluster of Differentiation 79B (CD79b) Antibody

abx413839-25ug 25 ug
EUR 326.4

Human CD79B AssayLite Antibody (FITC Conjugate)

32245-05141 150 ug
EUR 513.6

Cluster of Differentiation 79B (CD79B) Antibody

20-abx001650
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Human CD79B AssayLite Antibody (PerCP Conjugate)

32245-05171 150 ug
EUR 565.2

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC941844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF594 conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC941844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF594 conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC801844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF680 conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC801844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF680 conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC701844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF770 conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC701844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF770 conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC881844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF488A conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC881844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF488A conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC811844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF680R conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC811844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF680R conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC051844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF405M conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC051844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF405M conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC041844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF405S conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC041844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF405S conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC401844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF640R conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC401844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF640R conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNCAP1844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNCAP1844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNCA1844-250 250uL
EUR 472.8
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), APC conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNCP1844-250 250uL
EUR 472.8
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), PerCP conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNCR1844-250 250uL
EUR 472.8
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), RPE conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNCH1844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNCH1844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNCB1844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), Biotin conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNCB1844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), Biotin conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNUB1844-100 100uL
EUR 316.8
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), Concentration: 0.2mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNUB1844-50 50uL
EUR 486
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), 1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNUB1844-500 500uL
EUR 615.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), Concentration: 0.2mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC471844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF647 conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC471844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF647 conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC611844-100 100uL
EUR 279.6
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF660R conjugate, Concentration: 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1844) Antibody

BNC611844-500 500uL
EUR 654
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF660R conjugate, Concentration: 0.1mg/mL

Throughout the text we highlight the advantages and disadvantages of each methodology and discuss the most promising developments in their path from bench to bedside.

Leave A Comment